Metabolic Syndrome. Metabolic syndrome
Conditions
Interventions
Intervention 1: The intervention group: The patient with metabolic syndrome receiving a capsule containing 600 mg hydro-alcoholic extract of shallot twice daily (with breakfast and dinner) for 12 wee
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All individuals that metabolic syndrome was diagnosed by sepecialist
Exclusion criteria
Exclusion criteria: Cardiovascular disease Acute lung disease Infection with hepatitis B and C Cushing's syndrome Having polycystic ovary syndrome HIV Taking fat-lowering drugs Consumption of glucocorticoids Taking immunosuppressive drugs Taking antipsychotic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of glucose. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Autoanalyzer.;Serum level of LDL-C. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Autoanalyzer.;Serum level of triglyceride. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Autoanalyzer.;Body Mass Index. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Digital scales and meters.;Blood pressure. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Barometer.;Serum level of HDL-C. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum level of malondialdehyde. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Kit and ELISA reader device.;Serum level of superoxide dismutase. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Kit and ELISA reader device.;Serum level of LDL oxide. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Kit and ELISA reader device.;Serum level of beta-2 glycoprotein 1. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Kit and ELISA reader device.;Serum level of total antioxidant capacity. Timepoint: Before the intervention and 3 months after consuming the hydroalcoholic extract of Iranian shallot. Method of measurement: Kit and ELISA reader device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Mahmoodi
Kerman University of Medical Sciences
Outcome results
None listed